Maurizio D’Incalci was born in Milan in 1952 and obtained his Medical degree cum laude from the University of Milan in 1977. After specializing in pharmacology at the Mario Negri Institute of Milan and in oncology at the University of Genoa, he worked in the Laboratory of Molecular Pharmacology of the National Cancer Institute in Bethesda, MD, USA. Since 1986, he has been the Chief of the Laboratory of Cancer Chemotherapy at the Mario Negri, and, since 1996, he has become the Chief of the Department of Oncology at the Mario Negri. Currently, he is a Member of the Board of Directors of the Nerina and Mario Mattioli Onlus Foundation, Member of the Scientific Committee of the Italian Association for Cancer Research (AIRC), Member of the Board of Directors of the Italian Cancer Society (SIC), Member of the Scientific Committees of the ABO (Application of Biotechnologies in Oncology) Foundation, and Member of the Fondazione Buzzi Unicem Onlus for the research, diagnosis, and cure of malignant mesothelioma. He works as a Preclinical Coordinator of the Southern Europe New Drug Organization (SENDO), the Chairman of the New Agents Committee of SENDO, and the President of the Scientific Committee of the Mario Negri Gynecologic Oncology group (MaNGO). He is on the editorial board of many international cancer-related scientific journals. From September 2000 to December 2010, he has been Editor for Experimental Oncology of the European Journal of Cancer. D’Incalci is the author of more than 400 papers in peer-reviewed international journals and of several chapters in books on cancer chemotherapy and pharmacology.
Biography Updated on 21 October 2011